Skip to main content
# Title Department Research Member Research Year
41 FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy Department of Medical Oncology Dr. Salah Mabrouk Khallaf Abd Rabou 2023
42 FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy Department of Medical Oncology Dr. Amen Hamdy Zaki Ali 2023
43 Could Local Surgery Improve Survival in Stage IV Breast Cancer? Department of Surgical Oncology Abdelrahman Kamel Fathy Mohammed 2023
44 18F-FDG gallbladder uptake: observation from a total-body PET/CT scanner Department of Radiotherapy and Nuclear medicine Dr. Yasser Gaber Ali Abdelhafez 2023
45 FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy Department of Medical Oncology Dr. Shimaa Hassan Shabaan Hassan 2023
46 Could Local Surgery Improve Survival in Stage IV Breast Cancer? Department of Surgical Oncology Dr. Ahmed Refaat Abdel Zaher Mubarak 2023
47 Tumor Lymphocytic Infiltration as a Prognostic Factor in Gastric Carcinoma Department of Medical Oncology Dr. Marwa Tammam Ameen Hammam 2023
48 Value of FoxO3a Gene Expression in Pediatric Acute Lymphoblastic Leukemia Department of Clinical Pathology Dr. Doaa Fathi Hagag Ahmed 2023
49 Surgical Outcomes of Laparoscopic-assisted Distal Gastrectomy Versus Totally Laparoscopic Distal Gastrectomy Billroth I for Gastric Cancer Department of Surgical Oncology Dr. Badawy, Mohammed Ahmed Mohammed 2023
50 T-lymphocytes expression of Toll-like receptors 2 and 4 in acute myeloid leukemia patients with invasive fungal infections Department of Clinical Pathology Dr. Samar Muhammad mansour 2022